The biotech firm unveiled a $55 million private placement priced at a 13% premium to the previous session’s close.
Q32 Bio raised approximately $55 million in a private placement led by major healthcare investors as the company continues ...
Q32 Bio Inc. (QTTB) announced on Wednesday that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors for the private placement of ...
Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced the closing of its previously ...
On the back of stellar financial results, Aroa Biosurgery reckons it has only just begun to penetrate the capacious US market ...
Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a Phase 3 clinical-stage biotechnology company developing the ...
The Board of Directors of the Romanian pharmaceutical manufacturer Biofarm (BVB: BIO) officially approved the public takeover ...
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc.
Barchart on MSN
Are Wall Street analysts bullish on Bio-Techne stock?
With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, ...
Amish Shah, BofA Securities' Head of India Research, discusses India's energy security challenges. He sees increased ...
Q1 boat sales dip, margins rise, debt falls. ONEW trades near fair value at 8.4x adjusted EBITDA. Read more here.
The Bio Medica Laboratories IPO opened on May 21, with a price band of ₹132- ₹139. The company manufactures pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results